Heritage Family Offices’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
4,080
-1,643
-29% -$133K 0.12% 139
2026
Q1
$496K Sell
5,723
-1,706
-23% -$163K 0.22% 104
2025
Q4
$714K Sell
7,429
-653
-8% -$63.4K 0.32% 74
2025
Q3
$770K Sell
8,082
-129
-2% -$11.9K 0.36% 66
2025
Q2
$720K Hold
8,211
0.36% 67
2025
Q1
$738K Buy
8,211
+339
+4% +$30.3K 0.38% 65
2024
Q4
$629K Sell
7,872
-180
-2% -$15.6K 0.31% 70
2024
Q3
$725K Buy
8,052
+63
+0.8% +$5.3K 0.37% 59
2024
Q2
$629K Buy
+7,989
New +$655K 0.35% 68

Other funds holding MDT

Heritage Family Offices's MDT Position: Q2 2026 in Review

Heritage Family Offices reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $133K and leaving 4,080 shares worth $319K. The position accounts for 0.12% of the portfolio, ranked #139.

Heritage Family Offices first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $770K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Heritage Family Offices held 4,080 shares of Medtronic worth $319K as of Q2 2026.
  • Heritage Family Offices sold 1,643 Medtronic shares in Q2 2026, an estimated $133K.
  • Medtronic made up 0.12% of Heritage Family Offices's portfolio in Q2 2026, its #139 holding.
  • Heritage Family Offices first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Heritage Family Offices's Medtronic position peaked at $770K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Heritage Family Offices's 13F filing for Q2 2026, filed 29 Jul 2026.